The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Östra Sverige; Östra Mellansverige; Södermanlands län
Location of affected unit(s)
Strängnäs
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
2 October 2008
Employment effect (start)
31 December 2009
Foreseen end date
31 December 2009
Description
DSM Anti-Infectives is the world’s leading supplier of active pharmaceutical ingredients such as Amoxicillin, Ampicillin, Cephalexin and Cefadroxil; the worlds most widely used broad spectrum antibiotics for combating bacterial infections. In June 2007, DSM Anti-Infectives announced the outcome of its strategic review. Through a partnering strategy combined with innovation initiatives and restructuring measures, DSM believes the greatest value will be generated. As part of the review, clavulanic acid was not considered a long term strategic product for the group. Since June 2007 several options were evaluated, resulting in the decision to close the site in Strängnäs. The production will be terminated and the factory will close down at the end of 2009.
Eurofound (2008), DSM Anti-Infectives, Closure in Sweden, factsheet number 67201, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/67201.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...